RxDoctor Payments DataLook up a doctor →

Harold Yoon, MD

Radiation Oncology · Decatur, ILNPI 1558566984

Payments from drug & device makers

$65,902in general payments, 2019–2025

Across 885 payments — averaging $74.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$49K
  • Johnson & Johnson$2K
  • Merck$2K
  • AstraZeneca$2K
  • Novartis$1K
  • AbbVie$1K
  • plus $9K from 54 others

What the payments were for

  • Food & beverage$16,76899%
  • Education$1841%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pfizer36$49,204
Johnson & Johnson(3 entities)94$1,645
Merck99$1,577
AstraZeneca(2 entities)84$1,510
Novartis81$1,467
AbbVie41$1,092
Exelixis Inc.8$1,043
Daiichi Sankyo Inc.41$839
Lilly USA, LLC42$725
Eisai Inc.49$689
Pharmacyclics LLC, An Abbvie Company31$679
Amgen22$422
Genentech USA, Inc.22$365
Sanofi19$330
Bayer16$302
Regeneron Healthcare Solutions, Inc.13$283
Seagen Inc.14$279
Incyte Corporation15$270
Genmab U.S., Inc.9$238
Karyopharm Therapeutics Inc.8$202
Astellas Pharma US Inc9$173
Beigene USA, Inc.6$154
Gilead9$139
E.r. Squibb & Sons, L.L.C.7$137
Takeda Pharmaceuticals U.S.A., Inc.7$133
Mirati Therapeutics, Inc.5$121
Intuitive Surgical1$117
Blueprint Medicines Corporation6$108
Jazz Pharmaceuticals Inc.4$101
Stemline Therapeutics Inc.5$99
Sumitomo Pharma America, Inc.5$92
Rigel Pharmaceuticals, Inc.6$89
EMD Serono, Inc.5$84
Clovis Oncology, Inc.6$82
Bristol Myers Squibb5$74
G1 Therapeutics, Inc.4$72
Ipsen Biopharmaceuticals, Inc3$60
ADC Therapeutics America, Inc.3$59
Blue Earth Diagnostics2$54
Progenics Pharmaceuticals, Inc.1$53
Boehringer Ingelheim3$50
GSK3$50
Sun Pharmaceutical Industries Inc.2$45
AVEO Pharmaceuticals, Inc.2$43
Beone Medicines USA, Inc.2$41
Puma Biotechnology, Inc.3$39
Boston Scientific1$36
Agios Pharmaceuticals, Inc.2$28
Isoray, Inc2$27
Tempus AI, Inc1$22
Tolmar Pharmaceuticals, Inc.1$22
Brainlab, Inc.1$22
Dova Pharmaceuticals1$22
Morphosys, US Inc.1$22
Syndax Pharmaceuticals, Inc.1$20
Amneal Pharmaceuticals LLC1$19
Novocure Inc.1$19
Telix Pharmaceuticals1$18
Apellis Pharmaceuticals, Inc.1$18
Taiho Oncology, Inc.1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$65,902 in reported general payments places this provider in the 90th percentile of 242 radiation oncology providers in Illinois.

See all radiation oncology providers in Illinois

Medicare billing

Part B allowed, 2024
$675,237
Medicare patients
368
Services billed
7,969

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl96$1,055
Sucralfate15$433
Lorazepam11$13

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Decatur

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →